/PRNewswire-FirstCall/ -- PRO-DEX, INC. (Nasdaq: PDEX) today announced the appointment of Harold A. ("Hal") Hurwitz as Chief Financial Officer, effective
October 6, 2010
. Mr. Hurwitz succeeds
Jeffrey J. Ritchey
who has left the Company.
"Hal comes to Pro-Dex with a broad financial background that includes Big 4 public accounting experience as a Partner with Coopers & Lybrand LLP, now part of PricewaterhouseCoopers LLP, as well as public and private company financial management responsibility," commented
, Pro-Dex's Chief Executive Officer. "We are delighted to have Hal on our team to help accomplish the goals we have established." Commenting on Mr. Ritchey, Mr. Murphy continued, "On behalf of the entire Board of Directors, I want to thank Jeff for his dedication to Pro-Dex over the last nine years. We greatly appreciate the contributions he has made, particularly in having served the company in multiple capacities during its development. We wish him well in his future endeavors."
"I am privileged to be joining Pro-Dex at this exciting time," said Mr. Hurwitz. "Pro-Dex's ability to strengthen itself even through the uncertainties of the recent economic environment is impressive, and I look forward to being part of the leadership team that continues to build upon these strengths to position the company for future growth."
, Mr. Hurwitz was Vice President and Chief Financial Officer for Interventional Spine Inc., a medical device company focused on percutaneous systems for treatment of back pain. Prior to that, he was a Principal Consultant with McDermott & Bull, a retained executive search firm where he specialized in serving the life science industry. From 1997 through 2004, Mr. Hurwitz was Vice President and Chief Financial Officer for Micro Therapeutics, Inc., a developer and manufacturer of interventional neurovascular medical devices. Mr. Hurwitz began his career with Coopers & Lybrand LLP, where he served for 22 years, leading its life science and high technology practices in
Pro-Dex, Inc., with operations in
, specializes in bringing speed to market in the development and manufacture of technology-based solutions that incorporate miniature rotary drive systems, embedded motion control and fractional horsepower DC motors, serving the medical, dental, semi-conductor, scientific research and aerospace markets. Pro-Dex's products are found in hospitals, dental offices, medical engineering labs, commercial and military aircraft, scientific research facilities and high tech manufacturing operations around the world. For more information, visit the Company's website at
Statements herein concerning the Company's plans, growth and strategies may include 'forward-looking statements' within the context of the federal securities laws. Statements regarding the Company's future events, developments and future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. The Company's actual results may differ materially from those suggested as a result of various factors. Interested parties should refer to the disclosure concerning the operational and business concerns of the Company set forth in the Company's filings with the Securities and Exchange Commission.
SOURCE Pro-Dex, Inc.